Bank of Montreal’s Neuronetics STIM Stock Holding History

Bank of Montreal’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,648	Closed	-$7K	–	4663
2019 Q4	$7K	Buy	1,648 +499	+43%	+$3.1K	﹤0.01%	4643
2019 Q3	$10K	Buy	1,149 +46	+4%	+$503	﹤0.01%	4425
2019 Q2	$14K	Buy	+1,103	New	+$15.6K	﹤0.01%	4384
2019 Q1	–	Sell	-93	Closed	-$2K	–	4719
2018 Q4	$2K	Buy	93 +49	+111%	+$1.07K	﹤0.01%	4422
2018 Q3	$1K	Buy	+44	New	+$1.34K	﹤0.01%	4599

Other funds holding STIM

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Bank of Montreal's STIM Position: Q1 2020 in Review

Bank of Montreal sold out of Neuronetics (STIM) in Q1 2020, closing a stake of 1,648 shares — an estimated $7K sold.

Bank of Montreal first reported a position in STIM in Q3 2018 and held it in 5 quarters. The position peaked at $14K in Q2 2019. 59 funds tracked by Wall St. Rank hold STIM as of Q1 2020.

Bank of Montreal reported no remaining Neuronetics position as of Q1 2020 after selling out during the quarter.
Bank of Montreal sold 1,648 Neuronetics shares in Q1 2020, an estimated $7K.
Bank of Montreal first reported a position in Neuronetics in Q3 2018 and held it in 5 quarters.
Bank of Montreal's Neuronetics position peaked at $14K in Q2 2019.
59 funds tracked by Wall St. Rank held Neuronetics as of Q1 2020.

Based on Bank of Montreal's 13F filing for Q1 2020, filed 13 May 2020.